Contineum Therapeutics (CTNM) Current Leases (2023 - 2026)

Contineum Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Current Leases rose 58.28% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 58.28% YoY), while the FY2025 annual figure was $2.3 million, up 61.23% from the prior year.
• Current Leases was $2.3 million for Q1 2026 at Contineum Therapeutics, down from $2.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.3 million in Q4 2025 to a low of $464000.0 in Q4 2023.
• Historically, Current Leases has averaged $1.3 million across 4 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Current Leases soared 212.93% in 2024, then soared 58.28% in 2026.
• A 4-year view of Current Leases shows it stood at $464000.0 in 2023, then jumped by 212.93% to $1.5 million in 2024, then soared by 61.23% to $2.3 million in 2025, then declined by 1.62% to $2.3 million in 2026.
• The last three Current Leases figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.